Navigation Links
ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study

ights held by third parties, and such risks and uncertainties as detailed from time to time in ISTA's public filings with the U.S. Securities and Exchange Commission, including but not limited to ISTA's Annual Report on Form 10-K for the year ended December 31, 2006, and ISTA's Quarterly Report on Form 10-Q for the quarter ended March 31, 2007.

CONTACT: Vince Anido, Ph.D., +1-949-788-5311, , orLauren Silvernail, +1-949-788-5302, , both ofISTA Pharmaceuticals; Investors: Juliane Snowden, , orNicki Kahner, ; Media: Jason Farber,, or Kristin Faucette, , all ofBurns McClellan, +1-212-213-0006, for ISTA Pharmaceuticals vanido@istavision.com lsilvernail@istavision.com jsnowden@burnsmc.com nkahner@burnsmc.com jfarber@burnsmc.com kfaucette@burnsmc.com

Web site: http://www.istavision.com/

Ticker Symbol: (NASDAQ-NMS:ISTA)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA

Post Your Comments:
(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...FirstCall/ -- Caraco Pharmaceutical Laboratories, ...methamine ophthalmic solution, 0.5% following a fi...ion (FDA) for Sun Pharma,s Abbreviated New Drug Ap...c solution on the first day following patent expir...ly equivalent to Acular® Ophthalmic Solution,...
(Date:11/5/2009)... 5 Transcept Pharmaceuti...tical company focused on the development and comme...important therapeutic needs in the field of neuros... teleconference with management to discuss third q...r 12, 2009, at 5:00 p.m. Eastern Standard Time. F...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Gene findings revealing reasons for neuroblastoma risk 49275 1Gene findings revealing reasons for neuroblastoma risk 49275 2Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2
(Date:11/8/2009)...ADELPHIA, Nov. 8 The Am...he prevention and wellness provisions in the healt..., "With passage of this bill, the House takes impo...important insurance reforms and moving our health ...to one that focuses on keeping people healthy," sa...
(Date:11/8/2009)...er Costs and Crushing Taxes Nail Nation,s Job Crea...re/ -- In response to U.S. House passage of the he...ntrepreneurship Council (SBE Council) president &a...ent: ,, "Make no mistake, those voting for H.R...ith higher costs and crushing taxes and penalties....
(Date:11/8/2009)... Freeze-drying of biopharmaceutical...ga, Ontario facility. , ...lner, President and CEO of Therapure Biopharma Inc...ery of a commercial scale pharmaceutical grade fre...eze drying (lyophilization) available for contract...
(Date:11/8/2009)...ion,s largest network of Hispanic health advocates...orm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-...tatives showed they have heard the voice of Americ... for America Act. Now the Senate must deliver, wit...re reform," said Dr. Jane L. Delgado, President an...
(Date:11/8/2009)...P Praises House Passage of Health Care Reform Bill...icare, improve coverage for all Americans ,, C...he United States House of Representatives passed b...egislation that would strengthen Medicare for seni...that prices millions of Americans out of affordabl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...at the cox-2 inhibitor celecoxib, a common pain re...k of the most common cause of brain damage in pre...p blood vessels in a part of the brain that in pre...lastingly affected by cerebral palsy, mental retar...
...e risk of a type of kidney malignancy called renal...hers at Brigham and Women's Hospital in Boston fou...alcoholic beverage a day were about 30 percent les...nd other researchers reviewed data from 12 studies...
...s generally suffer in silence, cough up more money...th mixed results. And here comes the news tha...ring warranty on its workmanship, charging a flat ...nd the insurer another bill. Well the Geisin...
... a health authority in St. John's, Canada, has apo...tests that may have affected the care of hundreds...the Eastern Health Regional Authority agreed that ... that we didn't simply refer to it earlier,' Tille...
...of Cincinnati have developed a model that could im... helping physicians combine current clot-busting ...othermia. It is already known that lowerin...pproved stroke medication is an enzyme called tiss...
...s of the four sick public sector pharmaceutical an...overnments , the railways and the armed forces hav...hem profit making units. According to the ... Hindustan Organic Chemicals Limited have been rev...
Other Medicine News:Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 3Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:Researchers Develop Model That Aids in Treating Stroke Patients 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
Troponin I - Rapid Test
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
Roche/STAGO STA Compact
Medicine Products: